Streamlined generation of AAV using chemically-defined media

To view the webinar, please login to your account.

No account yet? Register.

Watch this 15-minute webinar and learn how Lonza's new TheraPEAK^® SfAAV^® Medium can help to streamline and accelerate the production of AAV in Sf9 cells.

The data presented by Senior Scientist Jerome Jacques shows how this new chemically-defined medium allows for increased AAV production, consistent cell growth and reduced downstream purification, streamlining process scale-up for the commercialization of gene therapies. 

Topics discussed

• Features and benefits of using TheraPEAK^® SfAAV^® Medium for gene therapy applications
• Performance comparison against other off-the-shelf media
• Production of different serotypes of AAV using TheraPEAK^® SfAAV^® Medium

Are you interested to learn more about the medium and its performance?
Would you like to test it?